通过减肥手术改善非酒精性脂肪性肝病
Improvement in nonalcoholic fatty liver disease through bariatric surgery.
作者信息
Truong Emily, Noureddin Mazen
机构信息
Department of Medicine Cedars-Sinai Medical Center Los Angeles California USA.
Cedars-Sinai Medical Center Los Angeles California USA.
出版信息
Clin Liver Dis (Hoboken). 2022 Jul 22;20(1):13-17. doi: 10.1002/cld.1229. eCollection 2022 Jul.
Abstract
Content available: Author Interview and Audio Recording.
摘要
提供的内容
作者访谈及音频记录。
相似文献
1
Improvement in nonalcoholic fatty liver disease through bariatric surgery.通过减肥手术改善非酒精性脂肪性肝病
Clin Liver Dis (Hoboken). 2022 Jul 22;20(1):13-17. doi: 10.1002/cld.1229. eCollection 2022 Jul.
2
The Shift from nonalcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease.从非酒精性脂肪性肝病到代谢功能障碍相关脂肪性肝病的转变
Clin Liver Dis (Hoboken). 2022 Nov 25;20(5):157-161. doi: 10.1002/cld.1250. eCollection 2022 Nov.
3
CON: Should patients with nonalcoholic steatohepatitis fibrosis undergo bariatric surgery as a primary treatment?反对观点：非酒精性脂肪性肝炎纤维化患者是否应将减肥手术作为主要治疗方法？
Clin Liver Dis (Hoboken). 2022 Jul 22;20(1):9-12. doi: 10.1002/cld.1226. eCollection 2022 Jul.
4
The impact of bariatric surgery on nonalcoholic fatty liver disease.减肥手术对非酒精性脂肪性肝病的影响。
Curr Opin Clin Nutr Metab Care. 2008 May;11(3):267-74. doi: 10.1097/MCO.0b013e3282fbd33f.
5
Duodenal mucosal resurfacing for nonalcoholic fatty liver disease.十二指肠黏膜重建治疗非酒精性脂肪性肝病
Clin Liver Dis (Hoboken). 2022 Nov 25;20(5):166-169. doi: 10.1002/cld.1255. eCollection 2022 Nov.
6
Intermittent Fasting as a Treatment for Nonalcoholic Fatty Liver Disease: What Is the Evidence?间歇性禁食作为非酒精性脂肪性肝病的一种治疗方法：证据有哪些？
Clin Liver Dis (Hoboken). 2022 Feb 3;19(3):101-105. doi: 10.1002/cld.1172. eCollection 2022 Mar.
7
The diagnosis and management of nonalcoholic fatty liver disease: A patient-friendly summary of the 2018 AASLD guidelines.非酒精性脂肪性肝病的诊断与管理：2018年美国肝病研究学会指南的患者友好型总结
Clin Liver Dis (Hoboken). 2022 Jul 1;19(6):222-226. doi: 10.1002/cld.1216. eCollection 2022 Jun.
8
The role of bariatric surgery in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.减肥手术在非酒精性脂肪性肝病和非酒精性脂肪性肝炎中的作用。
Expert Rev Gastroenterol Hepatol. 2017 Sep;11(9):797-811. doi: 10.1080/17474124.2017.1355731. Epub 2017 Jul 21.
9
Short-term outcome of bariatric surgery on nonalcoholic fatty liver disease: a Korean perspective.肥胖症手术对非酒精性脂肪性肝病的短期疗效：韩国视角
Ann Surg Treat Res. 2022 Jun;102(6):353-359. doi: 10.4174/astr.2022.102.6.353. Epub 2022 Jun 7.
10
The Effect of Bariatric Surgery on the Spectrum of Fatty Liver Disease.减重手术对脂肪性肝病谱的影响。
Can J Gastroenterol Hepatol. 2016;2016:2059245. doi: 10.1155/2016/2059245. Epub 2016 Sep 29.
引用本文的文献
1
Sarcopenia in MASLD-Eat to Beat Steatosis, Move to Prove Strength.代谢相关脂肪性肝病中的肌肉减少症——合理饮食以对抗脂肪变性，适度运动以增强力量。
Nutrients. 2025 Jan 2;17(1):178. doi: 10.3390/nu17010178.
2
Metabolic Role of Autophagy in the Pathogenesis and Development of NAFLD.自噬在非酒精性脂肪性肝病发病机制及发展中的代谢作用
Metabolites. 2023 Jan 7;13(1):101. doi: 10.3390/metabo13010101.
本文引用的文献
1
Bariatric Surgery in NAFLD.非酒精性脂肪性肝病的减重手术治疗。
Dig Dis Sci. 2022 Feb;67(2):408-422. doi: 10.1007/s10620-021-07317-3. Epub 2022 Jan 4.
2
Association of Bariatric Surgery With Major Adverse Liver and Cardiovascular Outcomes in Patients With Biopsy-Proven Nonalcoholic Steatohepatitis.减肥手术与经活检证实的非酒精性脂肪性肝炎患者的肝脏和心血管主要不良结局的关联
JAMA. 2021 Nov 23;326(20):2031-2042. doi: 10.1001/jama.2021.19569.
3
Bariatric Surgery Provides Long-term Resolution of Nonalcoholic Steatohepatitis and Regression of Fibrosis.减重手术可长期解决非酒精性脂肪性肝炎并使肝纤维化消退。
Gastroenterology. 2020 Oct;159(4):1290-1301.e5. doi: 10.1053/j.gastro.2020.06.006. Epub 2020 Jun 15.
4
Comparison of methodological approaches to human gut microbiota changes in response to metabolic and bariatric surgery: A systematic review.比较代谢和减重手术后人类肠道微生物群变化的方法学方法：系统评价。
Obes Rev. 2020 Aug;21(8):e13025. doi: 10.1111/obr.13025. Epub 2020 Apr 6.
5
Bariatric surgery improves nonalcoholic fatty liver disease: a contemporary systematic review and meta-analysis.减重手术改善非酒精性脂肪性肝病：当代系统评价和荟萃分析。
Surg Obes Relat Dis. 2019 Mar;15(3):502-511. doi: 10.1016/j.soard.2018.12.002. Epub 2018 Dec 6.
6
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention.非酒精性脂肪性肝病和非酒精性脂肪性肝炎的全球负担：趋势、预测、危险因素和预防。
Nat Rev Gastroenterol Hepatol. 2018 Jan;15(1):11-20. doi: 10.1038/nrgastro.2017.109. Epub 2017 Sep 20.
7
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases.非酒精性脂肪性肝病的诊断与管理：美国肝病研究协会的实践指南
Hepatology. 2018 Jan;67(1):328-357. doi: 10.1002/hep.29367. Epub 2017 Sep 29.
8
EASL-EASD-EASO Clinical Practice Guidelines for the Management of Non-Alcoholic Fatty Liver Disease.欧洲肝脏研究学会（EASL）-欧洲糖尿病研究学会（EASD）-欧洲肥胖症研究学会（EASO）非酒精性脂肪性肝病管理临床实践指南
Obes Facts. 2016;9(2):65-90. doi: 10.1159/000443344. Epub 2016 Apr 8.
9
Obese patients after gastric bypass surgery have lower brain-hedonic responses to food than after gastric banding.胃旁路手术后肥胖患者的大脑对食物的愉悦反应低于胃束带手术后。
Gut. 2014 Jun;63(6):891-902. doi: 10.1136/gutjnl-2013-305008. Epub 2013 Aug 20.
10
Predictive value of ALT levels for non-alcoholic steatohepatitis (NASH) and advanced fibrosis in non-alcoholic fatty liver disease (NAFLD).丙氨酸氨基转移酶水平对非酒精性脂肪性肝病患者非酒精性脂肪性肝炎（NASH）和肝纤维化的预测价值。
Liver Int. 2013 Oct;33(9):1398-405. doi: 10.1111/liv.12226. Epub 2013 Jun 13.
Zotero 插件